ADHD

Maria Asimopoulos  Psychiatry | July 22, 2025
The FDA is revising the labeling of all extended-release ADHD medications to warn about adverse reactions in young children.
Read More
Physician's Weekly EditorsPrimary Care | June 4, 2025
ADHD Diagnosis & Management Strategies for Primary Care, Part 2
Physician's Weekly EditorsPrimary Care | May 28, 2025
ADHD Diagnosis & Management Strategies for Primary Care, Part 1
Podcasts
August 27, 2025